Lawrence A. Leiter, M.D., F.R.C.P. (C), F.A.C.P.

Professor Departments of Medicine and Nutritional Sciences St. Michael's Health Centre 61 Queen Street East 6th Floor Toronto, Ontario M5C 2T2 Canada Tel: (416) 867 7441 Fax: (416) 864 5070 Email: leiter@smh.toronto.on.ca

Research

My major clinical research areas include:
a) dietary and pharmacologic treatment fo obesity, hyperlipidemia and diabetes,
b) appetite regulation including effects of sweeteners,
c) adverse effects of dieting and
d) metabolic control vs. complications of diabetes .

Selected Publications

• DCCT Research Group. The effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial. Ann Intern Med, 128:518-523. 1998.
• Leiter, LA, Bhalla, Pankaj. Atorvastatin calcium. A new HMG-CoA reductase inhibitor. Can J Clin Pharmacol; 5(3):138-154. 1998.
• Chiasson J-L, Gomis R, Hanefeld M, Leiter, L, et al. The STOP-NIDDM Trial. Diabetes Care, 21:1720-1725. 1998.
• Campbell, NRC, Burgess E, Taylor G, Wilson E, Cleroux J, Fodor JG, Leiter L, Spence JD. Canadian Recommendations for Lifestyle Modification to Prevent and Control Hypertension. Can Med Assoc J. (In Press). 1999.